Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)

Status Completed

Clinical Trial Summary

This is a prospective pharmacogenomics study of mood stabilizer response. The goal of this work is to identify genes associated with good response of patients with bipolar disorder to two commonly used mood stabilizing agents, lithium and valproate.

Clinical Trial Description

All subjects meeting study inclusion criteria will be started on lithium. Those that fail lithium will be crossed over to valproate (VPA). Those that also fail VPA will be again crossed-over to a standardized treatment as usual (TAU) arm. Subjects who are eligible for the study must be at least 18 years of age and have been diagnosed or are thought to have bipolar I disorder with at least one episode of mood instability in the last 12 months. They must also be eligible to take lithium and, if female and of child bearing age, agree to use adequate birth control methods and to inform their doctor of their plans to become pregnant. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01272531
Study type	Observational
Source	University of California, San Diego
Contact
Status	Completed
Phase
Start date	April 2011
Completion date	April 2016

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03275714` - Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder	N/A
Completed	`NCT03249857` - Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.	N/A
Completed	`NCT01722344` - Improving Work Outcome for People With Severe Mental Illness	N/A
Completed	`NCT01431092` - Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia	Phase 4
Completed	`NCT01315028` - Bipolar Intervention Study: Cognitive Interpersonal Therapy	N/A
Terminated	`NCT00805493` - Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder	Phase 2
Completed	`NCT00436020` - rTMS in the Treatment of Bipolar Depression	N/A
Withdrawn	`NCT00397605` - Cannabinoids in Bipolar Affective Disorder	N/A
Recruiting	`NCT05860101` - Compassion-Focused Therapy for Distressing Mood Swings: A Case Series	N/A
Recruiting	`NCT06176456` - Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia	N/A
Terminated	`NCT03310593` - Cannabidiol as an Adjunctive Treatment for Bipolar Depression	Phase 2/Phase 3
Recruiting	`NCT05406414` - The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems	N/A
Completed	`NCT02773108` - Somatic Comorbidities in Psychiatric Patients
Recruiting	`NCT00474357` - Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy	N/A
Withdrawn	`NCT00327756` - Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder	Phase 2
Completed	`NCT02453217` - The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial	N/A
Completed	`NCT05683431` - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)	N/A
Not yet recruiting	`NCT05915312` - Exosome for Early Diagnosis of Bipolar Affective Disorder
Completed	`NCT00186758` - Transcranial Magnetic Stimulation in Bipolar Depression	Phase 4
Completed	`NCT02083978` - Bipolar Research Study Using MR Imaging	N/A